Araya Shambel, Gebreyohannes Zenebe, Tadlo Getachew, Gessew Gebreab Teklebirhan, Negesso Abebe Edao
Department of Medical Laboratory Science, College of Health Science Addis Ababa University Addis Ababa, Addis Ababa, 9086, Ethiopia.
Department of Medical Microbiology, Parasitology and Immunology St. Paul Hospital Millennium Medical College, Addis Ababa, Ethiopia.
Infect Drug Resist. 2023 May 8;16:2765-2773. doi: 10.2147/IDR.S402894. eCollection 2023.
and are important nosocomial pathogens in health-care settings. Both are intrinsically resistant to many drugs and are able to become resistant to the virtually most antimicrobial agents. An increasing prevalence of infections caused by multidrug-resistant isolates has been reported in many countries.
An institutional-based cross-sectional five-year retrospective study was conducted to assess the antimicrobial resistance trend of and . 893 and 729 isolates were included in the study. Conventional method was used for identification and antimicrobial susceptibility was determined by Kirby-Bauer disc-diffusion method. The isolates were from suspected bloodstream infections, wound infections, urinary tract, or surgical site nosocomial infections. Socio-demographic and other variables of interest were collected using a structured check list from a patient record data. Data were analyzed using SPSS version 26 software. P value <0.05 was considered statistically significant.
A total of 1622 and were isolated from various clinical specimens recorded from the year 2017-2021. Out of which was 893 (60.6%) and was 729 (39.4%). Blood was the major source of the isolates (18.3%), followed by urine (16%), and tracheal aspirate (10.6%). Antimicrobial resistance among over the five years were; ampicillin (86% to 92%), ceftriaxone (66.7% to 82.2%), and ciprofloxacin (58.5% to 66.7%). In a significant increase in resistance was seen from 2017 to 2021 to Amoxicillin-clavulanate (74.1% to 84.2%), chloramphenicol (62% to 81.9%), and gentamicin (40% to 44.8%).
A five-year antimicrobial resistance trend analysis of and showed increasing multi drug resistance and resistance to highly potent antimicrobial agents in Ethiopia. It should be addressed with infection control measures, surveillance, and alternative new therapeutic strategies to circumvent the spread of multi-drug resistance.
[病原体名称1]和[病原体名称2]是医疗机构中重要的医院感染病原体。两者对许多药物都具有内在抗性,并且几乎能够对大多数抗菌药物产生耐药性。许多国家都报告了由多重耐药菌株引起的感染患病率不断上升。
进行了一项基于机构的横断面五年回顾性研究,以评估[病原体名称1]和[病原体名称2]的抗菌耐药趋势。该研究纳入了893株[病原体名称1]和729株[病原体名称2]分离株。采用常规方法进行鉴定,并通过 Kirby-Bauer 纸片扩散法测定抗菌药物敏感性。这些分离株来自疑似血流感染、伤口感染、尿路感染或手术部位医院感染。使用结构化检查表从患者记录数据中收集社会人口统计学和其他感兴趣的变量。使用SPSS 26版软件进行数据分析。P值<0.05被认为具有统计学意义。
2017年至2021年期间,从各种临床标本中总共分离出1622株[病原体名称1]和[病原体名称2]。其中[病原体名称1]有893株(60.6%),[病原体名称2]有729株(39.4%)。血液是分离株的主要来源(18.3%),其次是尿液(16%)和气管吸出物(10.6%)。五年间[病原体名称1]对以下抗菌药物的耐药率分别为:氨苄西林(86%至92%)、头孢曲松(66.7%至82.2%)和环丙沙星(58.5%至66.7%)。对于[病原体名称2],2017年至2021年期间对阿莫西林-克拉维酸(74.1%至84.2%)、氯霉素(62%至81.9%)和庆大霉素(40%至44.8%)的耐药率显著增加。
对[病原体名称1]和[病原体名称2]进行的五年抗菌耐药趋势分析表明,埃塞俄比亚的多重耐药性以及对高效抗菌药物的耐药性在增加。应通过感染控制措施、监测和替代性新治疗策略来应对,以避免多重耐药性的传播。